Liying Hao

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Cancer Stem Cells

Atrial Fibrillation

Dna Damage Response

Top Venues

Cardiovascular therapeutics

Channels (Austin, Tex.)

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Zheng, Fuxiang Su, Ze Kang, Jingyuan Li, Chenyang Zhang, Yujia Zhang, Liying Hao
Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy. Cardiovascular therapeutics 2022 (2022)
Yu Sun, Dan Dong, Yuhong Xia, Liying Hao, Wei Wang, Chenghai Zhao
YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance. Cell death & disease 13 (3) (2022)
Jingyuan Li, Siqi Wang, Jie Zhang, Yan Liu, Xi Zheng, Fan Ding, Xuefei Sun, Meimi Zhao, Liying Hao
The CaMKII phosphorylation site Thr1604 in the CaV1.2 channel is involved in pathological myocardial hypertrophy in rats. Channels (Austin, Tex.) 14 (1) (2021)